BDNF and Alzheimer disease: BDNF can potentially be used as an objectively accurate AD biomarker as it correlates and is directly linked with the cerebral phenomenon of AD, and decreased BDNF levels are also correlated with the degree of cognitive decline and neurological impairment reflecting the AD progressivity24,25.